Cabozantinib and Vandetanib in medullary thyroid carcinoma: mitochondrial function and its potential as a therapeutic target towards novel strategies to design anti-CSCs drugs

DOI: 10.1080/15384047.2018.1433495

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text